SCHEMBL30397368

CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCSC)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](N)[C@@H](C)O)[C@@H](C)O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)O)[C@@H](C)O)C(C)C)C(C)C)[C@@H](C)O

nearest known ligand 0.82

Predicted protein targets (top 8)

	gene	UniProt	supporting neighbours	confidence
▸	NPY2R	P49146	10/20	0.82

▸	NPY4R	P50391	8/20	0.82

▸	NPY5R	Q15761	8/20	0.82

▸	NPY1R	P25929	8/20	0.82

▸	TFPI	P10646	5/20	0.72

▸	GLP1R	P43220	2/20	0.69

▸	CALCR	P30988	2/20	0.69

▸	RAMP3	O60896	1/20	0.69

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compound	similarity	top predicted	shared targets
SCHEMBL31146614	0.93	NPY2R (0.73)	NPY2RNPY4RNPY5RNPY1RTFPI
SCHEMBL29361667	0.92	NPY2R (0.81)	NPY2RNPY4RNPY5RNPY1RGLP1R
SCHEMBL29399759	0.92	NPY2R (0.89)	NPY2RNPY4RNPY5RNPY1RTFPI
SCHEMBL29360287	0.91	NPY2R (0.71)	NPY2RNPY4RNPY5RNPY1RTFPI
Human Neuropeptide Y SCHEMBL29780330	0.91	NPY2R (0.79)	NPY2RNPY4RNPY5RNPY1RTFPI
SCHEMBL30578732	0.91	NPY2R (0.74)	NPY2RNPY4RNPY5RNPY1RTFPI
SCHEMBL30121639	0.91	NPY2R (0.92)	NPY2RNPY4RNPY5RNPY1RTFPI
SCHEMBL29977603	0.90	NPY2R (0.69)	NPY2RNPY4RNPY5RNPY1RTFPI
SCHEMBL30495784	0.90	NPY2R (0.70)	NPY2RNPY4RNPY5RNPY1RTFPI
SCHEMBL4331434	0.89	NPY2R (0.75)	NPY2RNPY4RNPY5RNPY1RTFPI

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

Patent	Title	Assignee	Published	Priority	Filing	Country	Status
US-20260097094-A1	METHODS FOR INHIBITING DIAZEPAM BINDING PROTEIN	INST NAT SANTE RECH MED (FR)	2026-04-09	—	—	US	disclosed
US-12343376-B2	Methods for inhibiting diazepam binding protein	Institut National de la Santé et de la Recherche Médicale (FR)	2025-07-01	—	—	US	disclosed
US-20240245750-A1	METHODS FOR INHIBITING DIAZEPAM BINDING PROTEIN	UNIVERSITÉ PARIS CITÉ (FR)	2024-07-25	—	—	US	disclosed
US-11905330-B1	Methods for weight reduction	INSERM (Institut National de la Santé et de la Recherche Médicale) (FR)	2024-02-20	—	—	US	disclosed
US-20230142694-A1	METHODS FOR TREATING LIVER DISEASE	UNIVERSITÉ PARIS CITÉ (FR)	2023-05-11	—	—	US	disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

Patent	Title	Text reads most about	Predicted target · text-rank
US-20260097094-A1	METHODS FOR INHIBITING DIAZEPAM BINDING PROTEIN	DBI, MAP1LC3B, BECN1	NPY2R 2025/4885NPY4R 736/4885NPY5R 1617/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.